Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment
NCT ID: NCT07124689
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2025-08-09
2025-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with central sensitization
Patients with a score of 40 or higher on theCentral Sensitization Inventory
Treatment outcome
Patients will be evaluated for their central sensitization scores before the injection, the pain they experienced during the injection 1 hour after the injection, their daytime and nighttime pain intensity before and 1 month after the injection, their pain thresholds for tactile sensation around the shoulder, and their pain and disability levels.
Patients without central sensitization
Patients with a score below 40 on the Central Sensitization Inventory
Treatment outcome
Patients will be evaluated for their central sensitization scores before the injection, the pain they experienced during the injection 1 hour after the injection, their daytime and nighttime pain intensity before and 1 month after the injection, their pain thresholds for tactile sensation around the shoulder, and their pain and disability levels.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment outcome
Patients will be evaluated for their central sensitization scores before the injection, the pain they experienced during the injection 1 hour after the injection, their daytime and nighttime pain intensity before and 1 month after the injection, their pain thresholds for tactile sensation around the shoulder, and their pain and disability levels.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than one-third of the active and passive movement of the painful shoulder is limited in two or more planes
* Having pain and limited movement in the shoulder for 3-12 months
Exclusion Criteria
* Patients with incomplete study data
* Having cervical radiculopathy
* Having a predominant central sensitization syndrome (such as fibromyalgia, chronic fatigue syndrome)
* Patients taking antidepressants or anticonvulsants that may affect central sensitization
* Having a history of rheumatological disease
* Having a history of active malignancy
* Patients receiving treatment for active psychiatric disorders
* Having a history of trauma and/or surgery in the same shoulder region
* Patients who received local shoulder injections and/or physical therapy within the last 3 months
* Patients with calcific tendonitis, glenohumeral osteoarthritis, or acromioclavicular joint osteoarthritis on plain radiographs
* Having a full-thickness rotator cuff tear on shoulder ultrasound
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sultan 1. Murat State Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alper Mengi
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sultan 1. Murat State Hospital
Edirne, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26/06/2025-Number:37
Identifier Type: -
Identifier Source: org_study_id